BARD BIOPTY-CUT BIOPSY NEEDLE WITH SPACER— 510(k) K910720

Substantially Equivalent

C.R. Bard, Inc.

FDA 510(k) clearance K910720 for BARD BIOPTY-CUT BIOPSY NEEDLE WITH SPACER, Substantially Equivalent on 1991-06-10. Applicant: C.R. Bard, Inc..

Clearance details

Applicant
C.R. Bard, Inc.
Product code
Code FCG
Advisory panel
Gastroenterology, Urology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Covington, GA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code FCG

product code FCG
Death
13
Injury
576
Malfunction
1,966
Total
2,555

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.